Clinical Trial Update: The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effects of Aplindore on signs and symptoms of Restless Legs Syndrome has completed. The study was sponsored by Ligand Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Aplindore (aplindore)

Snippet

Sponsor: Ligand Pharmaceuticals | Conditions: Restless Legs Syndrome | Phase 2 | Status: COMPLETED